Overview
Supported by Ferring Pharmaceuticals
The Dinner Meeting will look to navigate across three challenging case studies. The cases will cover locally advanced prostate cancer, through to cancer recurrence with oligometastatic features and castration-resistant metastatic disease. Current diagnostic and management options will be discussed, and there will be the opportunity for audience participation through interactive voting and a Q&A session.
